Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$110.08 - $142.92 $350,054 - $454,485
-3,180 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$99.73 - $148.48 $24 Million - $35.8 Million
-241,146 Reduced 98.7%
3,180 $438,000
Q3 2021

Nov 15, 2021

BUY
$98.85 - $138.91 $17 Million - $23.8 Million
171,546 Added 235.7%
244,326 $33.9 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $4.78 Million - $7.63 Million
72,642 Added 52639.13%
72,780 $7.07 Million
Q1 2021

May 13, 2021

SELL
$64.07 - $91.75 $6.75 Million - $9.66 Million
-105,284 Reduced 99.87%
138 $9,000
Q4 2020

Feb 12, 2021

BUY
$65.07 - $98.24 $136,712 - $206,402
2,101 Added 2.03%
105,422 $9.04 Million
Q3 2020

Nov 12, 2020

BUY
$59.04 - $77.95 $698,029 - $921,602
11,823 Added 12.92%
103,321 $6.72 Million
Q2 2020

Aug 13, 2020

BUY
$29.01 - $74.23 $2.65 Million - $6.79 Million
91,498 New
91,498 $6.69 Million
Q3 2019

Nov 14, 2019

SELL
$37.38 - $49.47 $3.43 Million - $4.53 Million
-91,638 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$39.79 - $67.01 $6.13 Million - $10.3 Million
-154,120 Reduced 62.71%
91,638 $4.01 Million
Q1 2019

May 10, 2019

BUY
$34.52 - $53.29 $7.58 Million - $11.7 Million
219,538 Added 837.29%
245,758 $12.6 Million
Q4 2018

Feb 13, 2019

BUY
$29.75 - $42.9 $780,045 - $1.12 Million
26,220 New
26,220 $969,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.